Anaxago

Anaxago is a French private investment platform that aggregates retail and accredited capital into venture, real estate, and private debt vehicles, with a multi-decade track record in the French market. Their venture activity is generalist by design, spanning consumer, fintech, B2B software, and selective healthcare deals where the business looks like a scalable French or European company. For healthcare AI founders, Anaxago is most relevant if you are raising a Series A or B in France or francophone Europe and want a capital-aggregation platform alongside an institutional lead. Check sizes are plausibly EUR 500K to 3M, deployed through dedicated funds or club deals depending on the vintage. Stage focus is typically Series A and Series B. Founders who should approach: French or European digital health companies with revenue, a clear path to profitability, and a story that resonates with retail-investor narratives — telemedicine, employer health, mental health, and consumer health products are likely better fits than B2B clinical decision support. Founders who should not approach: pre-revenue science plays, US-only companies, and biotech that requires specialized scientific syndicates. Entry path is direct application through the Anaxago platform or warm introduction through a French VC co-investor; their team is responsive to inbound for businesses that fit the platform’s typical risk-return profile. Be prepared for a diligence process that emphasizes financial metrics and regulatory clarity, since the underlying capital base expects mid-market private-investment standards. Their Crunchbase profile lists prior deals that map the typical transaction.